|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.510 CNY | -1.05% |
|
+3.03% | -12.27% |
| Market Cap | 3.82B 566M 490M 457M 420M 793M 53.82B 802M 5.37B 2.11B 26.93B 2.13B 2.08B 89.18B | P/E 2024 |
35.9x | P/E 2025 | 88.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.07B 455M 394M 368M 338M 638M 43.3B 646M 4.32B 1.7B 21.67B 1.71B 1.67B 71.76B | EV / Sales 2024 |
7.4x | EV / Sales 2025 | 8.08x |
| Free-Float |
24.34% | Yield 2024 |
0.62% | Yield 2025 | 0.36% |
| 1 day | -1.05% | ||
| 1 week | +3.03% | ||
| Current month | +3.03% | ||
| 1 month | -9.56% | ||
| 3 months | -8.49% | ||
| 6 months | -17.86% | ||
| Current year | -12.27% |
| 1 week | 7.7 |  | 8.69 |
| 1 month | 7.7 | | 9.67 |
| Current year | 7.02 | | 10.89 |
| 1 year | 7.02 | | 13.15 |
| 3 years | 6.3 | | 14.55 |
| 5 years | 6.3 | | 28 |
| 10 years | 6.3 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jie Guo
CEO | Chief Executive Officer | 53 | 2023-04-05 |
Yi Ming Wu
DFI | Director of Finance/CFO | 57 | 2025-04-29 |
Hui Zhang
IRC | Investor Relations Contact | 44 | 2023-05-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Ye
CHM | Chairman | 53 | 2020-08-17 |
Xiao Ming Ying
BRD | Director/Board Member | 58 | 2012-07-31 |
Si Yu Shen
BRD | Director/Board Member | 44 | 2018-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.05% | +3.03% | -31.92% | -30.70% | 572M | |
| +0.56% | -2.61% | +22.17% | +67.88% | 49.54B | |
| +2.71% | +7.21% | +60.15% | +131.43% | 40.07B | |
| +0.66% | +0.12% | -1.25% | +19.98% | 12.4B | |
| -0.59% | -0.10% | +19.44% | +70.02% | 11.85B | |
| -0.38% | -0.95% | +30.00% | +133.18% | 9.1B | |
| +1.34% | +3.50% | +15.77% | +35.84% | 6.94B | |
| +1.67% | -4.86% | +36.73% | -14.17% | 6.88B | |
| -0.38% | +2.82% | +11.18% | +175.99% | 6.6B | |
| +0.79% | +3.84% | -29.57% | +15.81% | 5.63B | |
| Average | +0.51% | +1.60% | +13.27% | +60.53% | 14.96B | |
| Weighted average by Cap. | +0.99% | +1.65% | +28.39% | +82.25% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 512M 75.78M 65.63M 61.18M 56.27M 106M 7.21B 107M 719M 282M 3.61B 285M 278M 11.94B | 447M 66.15M 57.29M 53.4M 49.12M 92.73M 6.29B 93.76M 628M 246M 3.15B 248M 243M 10.42B |
| Net income | 128M 18.92M 16.38M 15.27M 14.05M 26.52M 1.8B 26.81M 179M 70.43M 900M 71.04M 69.48M 2.98B | 47.48M 7.03M 6.09M 5.68M 5.22M 9.86M 669M 9.97M 66.73M 26.19M 335M 26.42M 25.83M 1.11B |
| Net Debt | -734M -109M -94.1M -87.72M -80.68M -152M -10.33B -154M -1.03B -405M -5.17B -408M -399M -17.12B | -746M -111M -95.76M -89.26M -82.1M -155M -10.51B -157M -1.05B -412M -5.26B -415M -406M -17.42B |
Employees
319
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | CN¥8.510 | -1.05% | 6,980,087 |
| 26-08-04 | CN¥8.600 | +8.59% | 12,911,020 |
| 26-08-03 | CN¥7.920 | -4.12% | 11,946,643 |
| 26-07-31 | CN¥8.260 | +2.10% | 3,002,641 |
| 26-07-30 | CN¥8.090 | -2.06% | 4,125,680 |
- Stock Market
- Stocks
- 688247 Stock
Select your edition
All financial news and data tailored to specific country editions
